open
MOLBIO DIAMolbio Diagnostics IPO
Molbio Diagnostics is an innovative point-of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results within an hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care.
Advertisement (Slot: header)
Price Band
🔴
Lot Size
0 Shares
Issue Size
Approx ₹939.70 Crores
Current GMP
₹120 (Aug 18)
IPO Timeline
Open DateAugust 18, 2026
Close DateAugust 18, 2026
Basis of AllotmentTBA
Listing DateJanuary 1, 2026
Subscription Status
Overall subscription
Promoters
| Particular | Pre IPO Shares | Pre IPO % Shares | Post IPO Shares | Post IPO % Shares |
|---|---|---|---|---|
| Promoter and Promoter Group | 52,597,450 | 46.65% | 4,34,31,450 | 37.69% |
| Others* | 60,162,300 | 53.35% | 7,18,08,546 | 62.31% |
| Total | 11,27,59,750 | 100% | 11,52,39,996 | 100% |
Objects of the Issue
- Kotak Mahindra Capital Co. Ltd.
- IIFL Capital Services Ltd.
- Jefferies India Pvt. Ltd.
- Motilal Oswal Investment Advisors Ltd.